QIAGEN (QGEN), Denovo to Develop CDx Test for Lymphoid Cancer Posted byZacks Equity Research December 10, 2021 Leave a comment on QIAGEN (QGEN), Denovo to Develop CDx Test for Lymphoid Cancer QIAGEN (QGEN) will develop a diagnostic assay that can identify the Denovo Genomic Marker 1 in patients with lymphoid cancer.